tci Medicare Compliance & Reimbursement - 2015 Issue 12
Compliance: Overbill And Risk Paybacks Down The Road
Subscribe or sign in to view the full article.
Article Overview
This article discusses a government audit of billing and reimbursement for an injectable drug, highlighting how coding and payment discrepancies can trigger compliance scrutiny and future paybacks. It is relevant to coders, compliance staff, revenue cycle teams, and practices that bill Medicare and other payers for drug administration or specialty medication claims. The article focuses on audit findings, payer review activity, and the importance of validating claims before responding to payer inquiries.
Why This Topic Matters
It helps providers understand how overbilling and incorrect HCPCS reporting can lead to audits, frozen payments, and repayment obligations later.
What You Will Learn
- How audit activity can uncover payment discrepancies in drug claims
- Why payer verification requests deserve careful internal review
- How overpayment risk can arise from incorrect claim reporting
- What compliance issues may follow when billed units or diagnosis information do not align with the claim
Who Should Read This
- Medical coders
- Compliance officers
- Billing staff
- Revenue cycle professionals
- Provider practices
- Medicare billing teams
Codes Discussed
Subscribe or sign in to view the full article.
Thank you for choosing Find-A-Code, please Sign In to remove ads.


Quick, Current, Complete - www.findacode.com